These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 12707936

  • 1. Depression in Alzheimer's disease: the effect of serotonin receptor gene variation.
    Holmes C, Arranz M, Collier D, Powell J, Lovestone S.
    Am J Med Genet B Neuropsychiatr Genet; 2003 May 15; 119B(1):40-3. PubMed ID: 12707936
    [Abstract] [Full Text] [Related]

  • 2. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.
    Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S.
    Hum Mol Genet; 1998 Sep 15; 7(9):1507-9. PubMed ID: 9700207
    [Abstract] [Full Text] [Related]

  • 3. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.
    Assal F, Alarcón M, Solomon EC, Masterman D, Geschwind DH, Cummings JL.
    Arch Neurol; 2004 Aug 15; 61(8):1249-53. PubMed ID: 15313842
    [Abstract] [Full Text] [Related]

  • 4. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.
    Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, Bentham P, Lendon CL.
    Neurobiol Aging; 2008 Mar 15; 29(3):341-7. PubMed ID: 17098333
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
    Holmes C, Smith H, Ganderton R, Arranz M, Collier D, Powell J, Lovestone S.
    J Neurol Neurosurg Psychiatry; 2001 Dec 15; 71(6):777-9. PubMed ID: 11723200
    [Abstract] [Full Text] [Related]

  • 8. No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease.
    Micheli D, Bonvicini C, Rocchi A, Ceravolo R, Mancuso M, Tognoni G, Gennarelli M, Siciliano G, Murri L.
    J Alzheimers Dis; 2006 Dec 15; 10(4):371-8. PubMed ID: 17183148
    [Abstract] [Full Text] [Related]

  • 9. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Słopień A, Czerski PM, Leszczyńska-Rodziewicz A, Hauser J.
    Pharmacol Rep; 2005 Dec 15; 57(6):761-5. PubMed ID: 16382194
    [Abstract] [Full Text] [Related]

  • 10. Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome.
    Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O.
    J Clin Gastroenterol; 2004 Aug 15; 38(7):561-6. PubMed ID: 15232358
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic candidate genes and puerperal psychosis: an association study.
    Kumar HB, Purushottam M, Kubendran S, Gayathri P, Mukherjee O, Murthy AR, Ghosh S, Chandra P, Reddy YC, Benegal V, Brahmachari SK, Jain S.
    Psychiatr Genet; 2007 Oct 15; 17(5):253-60. PubMed ID: 17728663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease.
    McCulley MC, Day IN, Holmes C.
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan 01; 124B(1):50-3. PubMed ID: 14681913
    [Abstract] [Full Text] [Related]

  • 15. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.
    Holmes C, McCulley M, Nicoll JA, Alder JT, Chen CP, Francis PT.
    Neurosci Lett; 2007 Jun 08; 420(1):58-60. PubMed ID: 17481814
    [Abstract] [Full Text] [Related]

  • 16. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A, ITINAD Working Group.
    Neurobiol Aging; 2009 Sep 08; 30(9):1406-12. PubMed ID: 18179845
    [Abstract] [Full Text] [Related]

  • 17. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F, Bosco P, Signorelli M, Spada RS, Cosentino FI, Toscano G, Bonforte C, Muratore S, Prestianni G, Panerai S, Giambirtone MC, Gulotta E, Romano C, Salluzzo MG, Nicoletti F, Copani A, Drago F, Aguglia E, Ferri R.
    Eur Neuropsychopharmacol; 2012 Apr 08; 22(4):281-9. PubMed ID: 21924590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M, Wadelius M, Dahl ML, Hartvig P, Lindström L, Hammarlund-Udenaes M.
    J Psychiatr Res; 2008 Sep 08; 42(11):884-93. PubMed ID: 18086475
    [Abstract] [Full Text] [Related]

  • 20. 5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.
    Harmon JL, Wills LP, McOmish CE, Demireva EY, Gingrich JA, Beeson CC, Schnellmann RG.
    J Pharmacol Exp Ther; 2016 Apr 08; 357(1):1-9. PubMed ID: 26787771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.